BIOTECHNOLOGY

Tools & guides

There are numerous investment themes hitting the news, Kanish Chugh writes, and advisers need to be aware of how they can get access to these if clients are seeking expos...

image
Funds management

Tech and biotech stocks and index trackers that are contributing to help mitigate the current COVID-19 crisis are strategic pickups right now....

image
Funds management

Despite the world rushing to find a vaccine for COVID-19, biotech and healthcare funds have not been able to maintain their former strong returns. ...

image
Funds management

ETF Securities has launched the CURE exchange-traded fund, which will offer investors exposure to healthcare biotechnology companies....

image
sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

3 weeks 4 days ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month ago

Insignia Financial has confirmed it is considering a preliminary non-binding proposal received from a US private equity giant to acquire the firm. ...

1 week 3 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

5 days 16 hours ago

Specialist wealth platform provider Mason Stevens has become the latest target of an acquisition as it enters a binding agreement with a leading Sydney-based private equi...

4 days 20 hours ago